Clinical Research

We started clinical research years ago, and have worked with many pharmaceutical companies. We are a full service research center with an experienced team. 

We are conducting a research study that will evaluate saxagliptin/dapagliflozin combination compared with saxagliptin  (Onglyza)  alone and dapagliflozin  (Farxiga) alone, given as add on therapy to metformin, in patients with type 2 diabetes.

Qualified participants—

•             Are men and women, aged >  18 with a diagnosis of type 2 diabetes.

•             Stable metformin therapy alone at a dose of  > 1500mg per day.

•             Have a recent HbA1c > 7.5% (53 mmol/mol).

•             Have not been exposed to DPP-4 or SGLT-2 inhibitor.

Eligible participants will take study medication and attend 6 study visits during a 6 month period. This research study is expected to last for 6 months.